Hypertension in the elderly: Are we all on the same wavelength?

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA (2002) 36.26

Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ (2009) 17.73

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA (1991) 14.36

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61

Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet (1999) 7.65

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ (2008) 6.13

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91

Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA (1996) 5.63

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation (2007) 5.20

End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ (2006) 5.03

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) (1985) 4.98

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90

Atenolol in hypertension: is it a wise choice? Lancet (2004) 4.75

Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA (1994) 4.44

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med (1992) 3.81

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet (2000) 3.25

Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc (2007) 3.22

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension (2001) 3.16

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension (2000) 2.76

Systolic hypertension in older persons. JAMA (2004) 2.44

Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA (1997) 2.11

National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. National High Blood Pressure Education Program Working Group. Hypertension (1994) 1.98

Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med (2003) 1.98

Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol (2002) 1.61

Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med (1994) 1.56

Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol (1996) 1.32

Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation (2008) 1.23

Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens Suppl (1999) 1.20

Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc (1991) 1.10

Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hypertens (1996) 0.81

Genetic contribution of the endothelial nitric oxide synthase gene to high altitude adaptation in sherpas. High Alt Med Biol (2006) 0.92

Adaptation to high altitude in Sherpas: association with the insertion/deletion polymorphism in the Angiotensin-converting enzyme gene. Wilderness Environ Med (2008) 0.88

Acute mountain sickness in children at 4380 meters in the Himalayas. Wilderness Environ Med (2009) 0.85

Right temporal cerebral dysfunction heralds symptoms of acute mountain sickness. J Neurol (2007) 0.82

Increase in 6-hydroxymelatonin excretion in humans during ascent to high altitudes. J Clin Endocrinol Metab (2004) 0.76

Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas. Aviat Space Environ Med (2008) 0.75

Hypoxemia without persistent right-to-left pressure gradient across a patent foramen ovale: A clinical challenge. World J Cardiol (2013) 0.75

Mild functional ischemic mitral regurgitation following acute coronary syndrome: a retrospective study. Heart Views (2011) 0.75

Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude. High Alt Med Biol (2006) 0.75

Middle cerebral artery preponderance in ischemic stroke: a coincidence or fate? Med Hypotheses (2012) 0.75

Post percutaneous coronary intervention antiplatelet therapy: current perceptions, prospects and perplexity. Cardiol J (2011) 0.75